Select a Company
0.38 GHS 0 / 0%
As of 24-Mar-2025
Dannex Ayrton Starwin Plc
Health Care Pharmaceuticals & Biotechnology0.38 GHS 0 / 0%
As of 24-Mar-2025
Prev. Close
0.38
Volume
0
Turnover
GHS 0.00
Deals
--
Shares Outstanding
84.77 mln
Market Cap.
GHS 32.21 mln
Loading Chart ...
52W RANGE
0.38 - 0.38
1W
--
1M
--
3M
--
YTD
--
1Y
--
Profile
Announcements
News
Reports
Dividends
About the company
Dannex Ayrton Starwin (DAS Pharma) is a pharmaceutical manufacturing and distribution company in Ghana, formed by the merger of Dannex Plc, Ayrton Drugs Manufacturing Limited and Starwin Products Limited, in January 2020.
Website
www.dasplcgh.com
-
Website
www.dasplcgh.com
-
| SYMBOL DASPHARMA |
ISIN GHEDASP58306 |
| Founded 2020 |
Listed 2020 |
| Phone - |
FAX - |
- |
|
Competitors
| Intravenous Infusions Limited | 0.05 | -- |
| DASPHARMA | AGM notice | 15 Nov. 2022 |
| DASPHARMA | Appointment | 10 Dec. 2021 |
| DASPHARMA | EGM | 19 Mar. 2020 |
| DASPHARMA | EGM | 2 Mar. 2020 |
Research & Analysis
Annual & Financials Reports
| Annual Report | 2023 |
| Annual Report | 2022 |
| Annual Report | 2021 |
| Annual Report | 2020 |
